Who
In numbers
- Trades disclosed
- 22
- Buys
- 7
- Sells
- 0
- Bought
- $20K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Aug 2025
- Last trade
- 9 Oct 2026
- Last filed
- 9 Oct 2026
Companies traded
Activity over time
1 Nov 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Oct 2026filed 9 Oct 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Bought | $6,035505 at $11.95 | filing |
| 19 Aug 2026filed 20 Aug 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code F | $242K20,397 at $11.87 | filing |
| 19 Aug 2026filed 20 Aug 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code F | $242K20,397 at $11.87 | filing |
| 14 Aug 2026filed 14 Aug 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code A | $1.7M141,631 at $11.65 | filing |
| 14 Aug 2026filed 14 Aug 2026 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —719,679 at $0.00 | filing |
| 14 Aug 2026filed 14 Aug 2026 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —719,679 at $0.00 | filing |
| 14 Aug 2026filed 14 Aug 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code A | $1.7M141,631 at $11.65 | filing |
| 4 Aug 2026filed 6 Aug 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Bought | $4,370370 at $11.81 | filing |
| 4 Aug 2026filed 6 Aug 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Bought | $4,370370 at $11.81 | filing |
| 17 Feb 2026filed 17 Feb 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Bought | $25223 at $10.94 | filing |
| 17 Feb 2026filed 17 Feb 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Bought | $25223 at $10.94 | filing |
| 2 Feb 2026filed 2 Feb 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Bought | $24024 at $10.00 | filing |
| 2 Feb 2026filed 2 Feb 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Bought | $24024 at $10.00 | filing |
| 26 Jan 2026filed 2 Feb 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Bought | $24625 at $9.86 | filing |
| 26 Jan 2026filed 2 Feb 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Bought | $24725 at $9.86 | filing |
| 16 Jan 2026filed 16 Jan 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Bought | $1,279137 at $9.33 | filing |
| 16 Jan 2026filed 16 Jan 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Bought | $1,278137 at $9.33 | filing |
| 3 Nov 2025filed 7 Nov 2025 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Bought | $1,106177 at $6.25 | filing |
| 15 Aug 2025filed 19 Aug 2025 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —1,065,042 at $0.00 | filing |
| 15 Aug 2025filed 19 Aug 2025 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —473,352 at $0.00 | filing |
News
Neogen (NASDAQ:NEOG) and Becton, Dickinson and Company (NYSE:BDX) Financial ReviewNEOG · themarketsdaily.com · 20 Oct 2026Head-To-Head Analysis: Delcath Systems (NASDAQ:DCTH) & Neogen (NASDAQ:NEOG)NEOG · themarketsdaily.com · 18 Oct 2026
0 headlines in the last 90 days name Mikheal Nassif; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.